• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Tectonic Therapeutic, Inc. - Common Stock (NQ:TECX)

    18.25 +0.65 (+3.69%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Tectonic Therapeutic, Inc. - Common Stock

    < Previous 1 2 Next >
    Nasdaq Moves Lower; Meta Platforms Posts Strong Sales
     
    Via Benzinga
    There are notable gap-ups and gap-downs in today's session.
    Let's delve into the US markets on Thursday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks. 
    Via Chartmill
    IBM Posts Upbeat Earnings, Joins Oshkosh, Las Vegas Sands, Nokia, Quest Diagnostics And Other Big Stocks Moving Higher On Thursday
     
    Via Benzinga
    Dow Jumps Over 100 Points; Tesla Earnings Miss Views
     
    Via Benzinga
    Topics Earnings Stocks
    Stay updated with the stocks that are on the move in today's pre-market session.
    Let's have a look at what is happening on the US markets before the opening bell on Thursday. Below you can find the top gainers and losers in today's pre-market session. 
    Via Chartmill
    12 Health Care Stocks Moving In Thursday's Pre-Market Session
     
    Via Benzinga
    Tectonic Therapeutic Announces Positive Interim Data from Phase 1b Trial for TX45 in Patients with Group 2 Pulmonary Hypertension in HFpEF
    From Tectonic Therapeutic
    Via GlobeNewswire
    Top movers analysis one hour before the close of the markets on 2025-01-28: top gainers and losers in today's session.
    Keep an eye on the top gainers and losers in Tuesday's session, as they reflect the most notable price movements. 
    Via Chartmill
    Tectonic Therapeutic to Host KOL Event on the Unmet Need in Group 2 PH-HFpEF and TX45 as a Potential Treatment on Thursday, December 12, 2024
    From Tectonic Therapeutic
    Via GlobeNewswire
    Tectonic Therapeutic To Present on December 3rd, 2024 at the Piper Sandler Healthcare Conference
    From Tectonic Therapeutic
    Via GlobeNewswire
    Tectonic Therapeutic Announces Positive Phase 1a Results in AHA 2024 Presentation for TX45, a Long-acting, Fc-Relaxin Fusion Protein
    From Tectonic Therapeutic
    Via GlobeNewswire
    Tectonic Therapeutic Announces Third Quarter 2024 Financial Results and Recent Business Highlights
    From Tectonic Therapeutic
    Via GlobeNewswire
    Tectonic Therapeutic to Present Phase 1a Data at AHA 2024
    American Heart Association (AHA) poster to be presented on November 16, 2024 
    From Tectonic Therapeutic
    Via GlobeNewswire
    Tectonic Therapeutic Announces Favorable Phase 1a Safety, Tolerability and PK/PD Results for Lead Program TX45
    From Tectonic Therapeutic
    Via GlobeNewswire
    TECX Stock Earnings: Tectonic Therapeutic Misses EPS for Q2 2024
    TECX stock results show that Tectonic Therapeutic missed analyst estimates for earnings per share the second quarter of 2024. 
    Via InvestorPlace
    Tectonic Therapeutic to Participate in September Investor Conferences
    From Tectonic Therapeutic
    Via GlobeNewswire
    Tectonic Therapeutic Announces Second Quarter 2024 Financial Results and Recent Business Highlights
    From Tectonic Therapeutic
    Via GlobeNewswire
    Tectonic Therapeutic Announces US IND Clearance for Lead Program, TX45
    From Tectonic Therapeutic
    Via GlobeNewswire
    < Previous 1 2 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.